ISSN: 1871-5303

Journal Home

Journal Guideline

Endocrine, Metabolic and Immune Disorders - Drug Targets Q3 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Endocrine, Metabolic and Immune Disorders - Drug Targets is a journal indexed in SJR in Immunology and Allergy and Endocrinology, Diabetes and Metabolism with an H index of 63. It has an SJR impact factor of 0,495 and it has a best quartile of Q3. It has an SJR impact factor of 0,495.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Endocrinology, Diabetes and Metabolism (Q3) Immunology and Allergy (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Endocrine, Metabolic and Immune Disorders - Drug Targets

0,495

SJR Impact factor

63

H Index

177

Total Docs (Last Year)

557

Total Docs (3 years)

10866

Total Refs

1227

Total Cites (3 years)

539

Citable Docs (3 years)

2.06

Cites/Doc (2 years)

61.39

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Current Opinion in Allergy and Clinical Immunology Q3
Journal of Immunological Methods Q3
Lymphology Q3
Allergo Journal International Q3
European Annals of Allergy and Clinical Immunology Q3

Compare this journals

Aims and Scope

Best articles by citations

The Association of Folic Acid Deficiency and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus

Factors Modulating Fibrates Response: Therapeutic Implications and Alternative Strategies

Future Targets for Immune Therapy in Colitis?

Effects of Olive Oil on TNF-a and IL-6 in Humans: Implication in Obesity and Frailty

In vitro Effects of Polyphenols on the Peripheral Immune Responses in Nickel-sensitized Patients

The AKT Axis as a Therapeutic Target in Autoimmune Diseases

HIV-Therapy Associated Lipodystrophy: Experimental and Clinical Evidence for the Pathogenesis and Treatment

Sevelamer Carbonate Markedly Reduces Levothyroxine Absorption

Insights into the Role of DNA Methylation and Protein Misfolding in Diabetes Mellitus

Drug Targeting Based on a New Concept-Targeting Against TLR4 as an Example

One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?

Therapeutic Targeting of B Lymphocyte Stimulator (BLyS) in the Rheumatic Diseases

SHOW MORE ARTICLES

Meet Our Editorial Board Member

Role of Probiotics and Functional Foods in Health: Gut Immune Stimulation by Two Probiotic Strains and a Potential Probiotic Yoghurt

Prolactin Induces IL-2 Associated TRAIL Expression on Natural Killer Cells from Chronic Hepatitis C Patients In vivo and In vitro

Role of the Gut Microbiota in Age-Related Chronic Inflammation

Eph as a Target in Inflammation

Editorial [ Sepsis: From the Bench to the Bedside ]

CCL2-CCR2 Signaling in Disease Pathogenesis

Therapeutic Effects of Melatonin On Liver And Kidney Damages In Intensive Exercise Model of Rats

In Silico Modeling of Crabtree Effect

Nitric Oxide and Cardiovascular Dysfunction in Sepsis

Blockade of Chemokine-Mediated Tissue Injury in Lupus Nephritis

Anti-Interleukin-6 Receptor Antibody Therapy in Rheumatic Diseases